Opinion
Video
Author(s):
Mickey Bryson recounts how Kristine Kucera, PA-C, MPAS, DHS, introduced a new medication and shared trial data with him, empowering him to make an informed decision about trying the new treatment.
Patients with Atopic Dermatitis Are More Susceptible to Developing Inflammatory Bowel Disease
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
FDA Approves Tapinarof Cream, 1% for Atopic Dermatitis in Patients 2 Years and Older
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
2024 Key Insights: Atopic Dermatitis
Pediatric and Adult AD Cases Illuminate Benefits of Topical PDE4 Inhibitors